15-GI-95-NLG (NLG2104): A Phase 1/2 Study of Indoximod in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas

  • Anthony, Lowell (PI)
  • Goel, Gaurav (Former PI)
  • Hosein, Peter (Former PI)
  • Mathew, Aju (Former PI)

Grants and Contracts Details

StatusFinished
Effective start/end date9/21/159/13/19

Funding

  • NewLink Genetics: $47,539.00